amifostine anhydrous and misoprostol

amifostine anhydrous has been researched along with misoprostol in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (22.22)	18.7374
1990's	3 (33.33)	18.2507
2000's	3 (33.33)	29.6817
2010's	1 (11.11)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Grdina, DJ; Hanson, WR	1
Collins, PW; Hanson, WR; Houseman, KA; Nelson, AK	1
Collins, PW; Hanson, WR; Houseman, KA	1
Kumar, S; Srinivasan, V; Weiss, JF	1
Baxter, S; Bogo, V; Clark, EP; Harris, AH; Hogan, JB; Kumar, KS; Landauer, MR; Palazzolo, D	1
Damron, TA; Farnum, CE; Horton, JA; Margulies, BS; Spadaro, JA; Strauss, JA	1
Damron, TA; Farnum, CE; Horton, JA; Luther, J; Margulies, BS; Spadaro, JA; Strauss, JA	1
Depeš, D; Falk, M; Hofer, M; Hoferová, Z	1

Reviews

2 review(s) available for amifostine anhydrous and misoprostol

Article	Year
Radiation protection in vivo by prostaglandins and related compounds of the arachidonic acid cascade. Pharmacology & therapeutics, 1988, Volume: 39, Issue:1-3 Topics: Alprostadil; Amifostine; Animals; Arachidonic Acids; Misoprostol; Prostaglandins; Radiation Injuries, Experimental; Radiation-Protective Agents	1988
Combining Pharmacological Countermeasures to Attenuate the Acute Radiation Syndrome-A Concise Review. Molecules (Basel, Switzerland), 2017, May-19, Volume: 22, Issue:5 Topics: Acute Radiation Syndrome; Amifostine; Animals; Dinoprostone; Drug Administration Schedule; Drug Combinations; Drug Synergism; Granulocyte Colony-Stimulating Factor; Humans; Metformin; Misoprostol; Radiation Injuries, Experimental; Radiation-Protective Agents; Vitamin E	2017

Article

Year

Radiation protection in vivo by prostaglandins and related compounds of the arachidonic acid cascade.

Pharmacology & therapeutics, 1988, Volume: 39, Issue:1-3

Topics: Alprostadil; Amifostine; Animals; Arachidonic Acids; Misoprostol; Prostaglandins; Radiation Injuries, Experimental; Radiation-Protective Agents

1988

Combining Pharmacological Countermeasures to Attenuate the Acute Radiation Syndrome-A Concise Review.

Molecules (Basel, Switzerland), 2017, May-19, Volume: 22, Issue:5

Topics: Acute Radiation Syndrome; Amifostine; Animals; Dinoprostone; Drug Administration Schedule; Drug Combinations; Drug Synergism; Granulocyte Colony-Stimulating Factor; Humans; Metformin; Misoprostol; Radiation Injuries, Experimental; Radiation-Protective Agents; Vitamin E

2017

Other Studies

7 other study(ies) available for amifostine anhydrous and misoprostol

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Misoprostol, a PGE1 analog, protects mice from fission-neutron injury. Radiation research, 1991, Volume: 128, Issue:1 Suppl Topics: Amifostine; Animals; Drug Therapy, Combination; Male; Mice; Misoprostol; Neutrons; Radiation Injuries, Experimental; Radiation-Protective Agents	1991
Radiation protection of the murine intestine by misoprostol, a prostaglandin E1 analogue, given alone or with WR-2721, is stereospecific. Prostaglandins, leukotrienes, and essential fatty acids, 1988, Volume: 32, Issue:3 Topics: Alprostadil; Amifostine; Animals; Intestines; Male; Mice; Misoprostol; Organothiophosphorus Compounds; Stereoisomerism	1988
Radioprotection by misoprostol (PGE1 methyl analog) in combination with vitamin E, selenomethionine and WR-3689794. Advances in experimental medicine and biology, 1997, Volume: 400B Topics: Amifostine; Animals; Confidence Intervals; Drug Synergism; Gamma Rays; Male; Mice; Mice, Inbred Strains; Misoprostol; Pseudomonas Infections; Radiation-Protective Agents; Selenomethionine; Survival Rate; Vitamin E	1997
Effects of eicosanoid radioprotectors on rat motor performance. Advances in experimental medicine and biology, 1997, Volume: 400B Topics: Amifostine; Analysis of Variance; Animals; Eicosanoids; Electric Stimulation; Iloprost; Lipid A; Male; Misoprostol; Motor Activity; Radiation-Protective Agents; Rats; Rats, Sprague-Dawley; Time Factors	1997
Combinations of radioprotectants spare radiation-induced damage to the physis. Clinical orthopaedics and related research, 2004, Issue:426 Topics: Amifostine; Animals; Body Weight; Bone Density; Bone Development; Drug Therapy, Combination; Femur; Growth Plate; Leg Length Inequality; Male; Misoprostol; Pentoxifylline; Radiation Dosage; Radiation Injuries, Experimental; Radiation-Protective Agents; Rats; Rats, Sprague-Dawley; Selenium; Tibia	2004
Radioprotectant combinations spare radiation-induced damage to the physis more than fractionation alone. International journal of radiation biology, 2005, Volume: 81, Issue:10 Topics: Amifostine; Animals; Anti-Ulcer Agents; Bone Development; Disease Models, Animal; Dose Fractionation, Radiation; Knee Joint; Male; Misoprostol; Pentoxifylline; Radiation Injuries; Radiation-Protective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Tibia	2005